Drug Side Effects
Search
BLADDER TRANSITIONAL CELL CARCINOMA STAGE 0
BLADDER TRANSITIONAL CELL CARCINOMA STAGE 0
was reported 26 times
BLADDER TRANSITIONAL CELL CARCINOMA STAGE 0 is most prevalent among patients taking these drug classes:
#
Drug class
Count
Frequency
0
CD38-directed Cytolytic Antibody [EPC]
4
0.0007
1
SLAMF7-directed Immunostimulatory Antibody [EPC]
2
0.0004
2
Glinide [EPC]
2
0.0002
3
Human Immunoglobulin G [EPC]
3
0.0001
4
Anticholinergic [EPC]
2
0.0001
5
Cholinergic Muscarinic Antagonist [EPC]
2
0.0001
6
Dihydrofolate Reductase Inhibitor Antibacterial [EPC]
4
0.0000
7
Erythropoiesis-stimulating Agent [EPC]
2
0.0000
8
Interleukin-17A Antagonist [EPC]
1
0.0000
9
P2Y12 Platelet Inhibitor [EPC]
3
0.0000
10
Xanthine Oxidase Inhibitor [EPC]
4
0.0000
11
Thalidomide Analog [EPC]
12
0.0000
12
Peroxisome Proliferator Receptor alpha Agonist [EPC]
1
0.0000
13
Sulfonylurea [EPC]
2
0.0000
14
Opioid Agonist [EPC]
4
0.0000
15
Insulin Analog [EPC]
5
0.0000
16
beta-Adrenergic Blocker [EPC]
3
0.0000
17
HMG-CoA Reductase Inhibitor [EPC]
3
0.0000
18
Corticosteroid [EPC]
10
0.0000
19
Aldosterone Antagonist [EPC]
1
0.0000
20
Dihydropyridine Calcium Channel Blocker [EPC]
2
0.0000
21
RANK Ligand Inhibitor [EPC]
1
0.0000
22
Proton Pump Inhibitor [EPC]
2
0.0000
23
Loop Diuretic [EPC]
1
0.0000
24
Platelet Aggregation Inhibitor [EPC]
1
0.0000
25
Nonsteroidal Anti-inflammatory Drug [EPC]
2
0.0000
26
Tumor Necrosis Factor Blocker [EPC]
1
0.0000